Cutting-Edge Depression Treatment Esketamine
To schedule a consultation and see if Esketamine is right for you, call us at 314-525-5050 or fill out our contact form and we will get in touch with you.
Our practice is pleased to announce the availability of Spravato (intranasal Esketamine) for the treatment of severe depression. Recently, research in this area has shown to have great promise in off-label treatment of severe depression, PTSD, OCD, drug and alcohol addiction, and other psychiatric diagnoses. This success led to extensive research in this treatment modality, which in turn led to the development of an intranasal form of this medication (Esketamine) that has recently received FDA approval.
Rather than being a first-line treatment, Esketamine is used when other antidepressants don’t work. However in some patients with moderate depression who for any reasons are unable to tolerate therapeutic doses of conventional antidepressants (or who has failed multiple treatments in the past), this treatment modality can successfully be utilized together with other prescribed medications. Esketamine has also been used in some cases of bipolar disorder, but it is not indicated for patients with active psychosis, mania, or for patients with unstable cardiovascular disease. It is not indicated to use in children.
The psychiatrists at CLTCP are experienced in this treatment method, and are committed to making it safely and effectively available to those patients who need it.
More information on Esketamine Treatment at CLTCP
More information about Spravato (intranasal Esketamine)
